Newsletter | January 20, 2026

01.20.26 -- Global Shifts And Strategic Resilience Will Shape CGT In 2026

SPONSOR

Simplified Harvest and Media Exchange in Cell Therapy: Consistent, Compliant Scale-Up from Development to GMP

Developing robust cell harvest and media exchange processes has become increasingly complex in GMP manufacturing. Variability from equipment, scale, and automation can delay timelines and impact product quality. In this webinar, CARR Biosystems shares case studies showing how low-shear, single-use centrifugation enables consistent harvest and media exchange across cell types while preserving CQAs. Click here to learn more.

FOCUS ON MANUFACTURING

Global Shifts And Strategic Resilience Will Shape CGT In 2026

Dr. Miguel Forte, CEO of Kiji Therapeutics and President of ISCT, and Ali Pashazadeh, Founder of Treehill Partners share why CGT developers are now navigating a landscape defined by geography, regulatory agility, and investment dynamics.

The Ultimate Guide To Stress-Free Pipetting

Improve accuracy and reduce stress with expert pipetting tips. Discover how technique and tool selection can boost precision and efficiency, ensuring consistent results across every lab workflow.

Extractables And Leachables In Advanced Therapy Medicinal Products

ATMPs challenge existing E&L practices in single-use manufacturing. Gain expert insight into regulatory gaps, risk management needs, and the urgency for tailored approaches.

Streamlining Vaccine Purification: Techniques For Modern Modalities

Explore cutting-edge chromatography techniques accelerating vaccine purification across diverse modalities, with case studies on HPV, Malaria, and COVID-19.

5 Key Questions On Implementing Pharma 4.0 Solutions For Fill-Finish

Pharma 4.0 leverages IoT, AI, and automation to enhance drug quality. Evaluate your fill-finish line readiness by considering five key questions on modularity, high-risk process automation, and data integration.

Cell Bank And Scale Up Strategies For MSC And Exosome Manufacturing

Discover how effective cell banking and scale-up strategies can reduce risk and cost in advanced therapy manufacturing. Learn practical ways to meet increasing cell and exosome quantity needs.

Vial Containment Systems For Gene Therapies: Recovery Of Viral Vectors

Vial containment systems were evaluated for maintenance of virus transducability after storage at ultralow temperature. All vectors showed equivalent or better function compared to standard systems.

Four Common Types Of Cryogenic Studies For Advanced Therapies

Learn why cryopreservation studies are so critical and how biopharmaceutical manufacturers can more easily navigate the complexities of this process.

Key Considerations For Shortening Your CAR-T Manufacturing Process

Optimize automated workflows to improve the potency and scalability of next-generation CAR-T cell therapies. Uncover strategies to accelerate vein-to-vein time and secure cell viability.

Innovations In CGT Processing

See how innovative connectors streamline workflows, save time, and enhance reliability in critical applications, ultimately supporting improved outcomes in cell and gene therapies.

Manufacturing Of CAR-T Cells: Automation And Defined Culture Conditions

The process associated with the manufacture of CAR-T cell therapies presents challenges that immensely impact patient accessibility to these treatments. Reducing manufacturing complexity is key.

Contamination In The Shadows: Risks Lurking From Environmental Issues

Read how science-based bio-decontamination strategies effectively eliminate invisible pathogens and rapidly restore facilities to operational safety following major infrastructure disruptions.

MANUFACTURING SOLUTIONS

A Cytokine Aids In Innate And Adaptive Immune Responses - Sartorius

Liquid Fill-Finish Platform - 3P innovation

Optimize Your Cell Line Strategy For Better Viral Vector Production - Cytiva

Solutions For mRNA-LNP Vaccine Production And Analysis - KNAUER

Connect With Cell & Gene: